CaixaBank, S.A.’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$38.2M Buy
203,270
+106,506
+110% +$19.1M 1.51% 12
2017
Q1
$16M Buy
96,764
+26,612
+38% +$4.23M 0.79% 23
2016
Q4
$10.1M Buy
+70,152
New +$9.39M 0.66% 26

Other funds holding ELV

CaixaBank, S.A.'s ELV Position: Q2 2017 in Review

CaixaBank, S.A. increased its Elevance Health (ELV) stake by 110% in Q2 2017, buying an estimated $19.1M and bringing the position to 203,270 shares worth $38.2M. The position accounts for 1.51% of the portfolio, ranked #12.

CaixaBank, S.A. first reported a position in ELV in Q4 2016 and has held it in 3 quarters since. 852 funds tracked by Wall St. Rank hold ELV as of Q2 2017.

  • CaixaBank, S.A. held 203,270 shares of Elevance Health worth $38.2M as of Q2 2017.
  • CaixaBank, S.A. bought 106,506 Elevance Health shares in Q2 2017, an estimated $19.1M.
  • Elevance Health made up 1.51% of CaixaBank, S.A.'s portfolio in Q2 2017, its #12 holding.
  • CaixaBank, S.A. first reported a position in Elevance Health in Q4 2016 and has held it in 3 quarters since.
  • 852 funds tracked by Wall St. Rank held Elevance Health as of Q2 2017.

Based on CaixaBank, S.A.'s 13F filing for Q2 2017.